Home/Filings/4/0001140361-12-034600
4//SEC Filing

MEDTOX SCIENTIFIC INC 4

Accession 0001140361-12-034600

CIK 0000739944operating

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 3:18 PM ET

Size

12.9 KB

Accession

0001140361-12-034600

Insider Transaction Report

Form 4
Period: 2012-07-31
WIERSMA KEVIN J
V.P., COO - Labs, and CFO
Transactions
  • Disposition to Issuer

    Common Stock

    2012-07-31$27.00/sh4,165$112,4550 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2012-07-31$27.00/sh15,000$405,0000 total
    Exercise: $4.41From: 2003-01-01Exp: 2013-01-01Common Stock (15,000 underlying)
  • Disposition to Issuer

    Common Stock

    2012-07-31$27.00/sh86,917$2,346,75934,210 total
  • Disposition to Issuer

    Non-Qualified Stock Option (right to buy)

    2012-07-31$27.00/sh30,000$810,0000 total
    Exercise: $3.70From: 2003-09-11Exp: 2013-12-31Common Stock (30,000 underlying)
  • Disposition to Issuer

    Common Stock

    2012-07-31$27.00/sh30,045$811,2154,165 total
Footnotes (5)
  • [F1]Disposition is exempt under Rule 16(b)(3)
  • [F2]Disposed of pursuant to merger agreement between issuer and Laboratory Corporation of America Holdings in exchange for $27.00 per share cash.
  • [F3]Attributable to non-qualified deferred compensation plan.
  • [F4]This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $23.30, representing the difference between the exercise price of the option and the $27.00 per share merger consideration.
  • [F5]This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $25.5933, representing the difference between the exercise price of the option and the $27.00 per share merger consideration.

Documents

1 file

Issuer

MEDTOX SCIENTIFIC INC

CIK 0000739944

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000739944

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 3:18 PM ET
Size
12.9 KB